Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2014 (2014), Article ID 507178, 8 pages
http://dx.doi.org/10.1155/2014/507178
Research Article

Preparation and Characterization of Kynurenic Acid Occluded in Sol-Gel Silica and SBA-15 Silica as Release Reservoirs

1Nanotechnology Laboratory, National Institute of Neurology and Neurosurgery, 14269 Mexico City, Mexico
2Department of Chemical and Molecular Engineering, Tulane University, New Orleans, LA 70118, USA
3Nanotechnology and Nanomedicine Laboratory, Autonomous Metropolitan University-Xochimilco, 04960 Mexico City, Mexico
4Institute of Physics, National Autonomous University of Mexico, 01000 Mexico City, Mexico
5Neurochemistry Department, National Institute of Neurology and Neurosurgery, 14269 Mexico City, Mexico
6Neuroscience Department, Subdivision of Neurobiology, National Institute of Rehabilitation, 14389 Mexico City, Mexico
7El Colegio Nacional, 06020 Mexico City, Mexico

Received 4 March 2014; Revised 9 May 2014; Accepted 9 May 2014; Published 29 May 2014

Academic Editor: Abdelwahab Omri

Copyright © 2014 Tessy López et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Kreuter, D. Shamenkov, V. Petrov et al., “Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier,” Journal of Drug Targeting, vol. 10, no. 4, pp. 317–325, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Miller, “Drug targeting: breaking down barriers,” Science, vol. 297, no. 5584, pp. 1116–1118, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Modi, V. Pillay, Y. E. Choonara, V. M. K. Ndesendo, L. C. du Toit, and D. Naidoo, “Nanotechnological applications for the treatment of neurodegenerative disorders,” Progress in Neurobiology, vol. 88, no. 4, pp. 272–285, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. A. V. Kabanov and H. E. Gendelman, “Nanomedicine in the diagnosis and therapy of neurodegenerative disorders,” Progress in Polymer Science, vol. 32, no. 8-9, pp. 1054–1082, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. T. M. Allen and P. R. Cullis, “Drug delivery systems: entering the mainstream,” Science, vol. 303, no. 5665, pp. 1818–1822, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Kortesuo, M. Ahola, S. Karlsson, I. Kangasniemi, J. Kiesvaara, and A. Yli-Urpo, “Sol-gel processed sintered silica xerogel as a carrier in controlled drug delivery,” Journal of Biomedical Material Research, vol. 44, pp. 162–167, 2000. View at Google Scholar
  7. M. Vallet-Regí, M. Colilla, and I. Izquierdo-Barba, “Bioactive mesoporous silicas as controlled delivery systems: application in bone tissue regeneration,” Journal of Biomedical Nanotechnology, vol. 4, no. 1, pp. 1–15, 2008. View at Google Scholar · View at Scopus
  8. S. Giri, B. G. Trewyn, M. P. Stellmaker, and V. S. Y. Lin, “Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles,” Angewandte Chemie, vol. 44, no. 32, pp. 5038–5044, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Signoretto, E. Ghedini, V. Nichele, F. Pinna, V. Crocell, and G. Cerrato, “Effect of textural properties on the drug delivery behaviour of nanoporous TiO2 matrices,” Microporous and Mesoporous Materials, vol. 139, no. 1–3, pp. 189–196, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Zhang, J. Zhang, T. Jiang, and S. Wang, “Inclusion of the poorly water-soluble drug simvastatin in mesocellular foam nanoparticles: drug loading and release properties,” International Journal of Pharmaceutics, vol. 410, no. 1-2, pp. 118–124, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. T. López, E. Ortiz, D. Meza et al., “Controlled release of phenytoin for epilepsy treatment from titania and silica based materials,” Materials Chemistry and Physics, vol. 126, no. 3, pp. 922–929, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Lopez, E. Ortiz, R. Alexander-Katz et al., “The effect of water on particle size, porosity and the rate of drug release from implanted titania reservoirs,” Journal of Biomedical Materials Research B, Applied Biomaterials, vol. 93, no. 2, pp. 401–406, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. T. López, J. L. Bata-García, D. Esquivel et al., “Treatment of parkinson's disease: nanostructured sol-gel silica-dopamine reservoirs for controlled drug release in the central nervous system,” International Journal of Nanomedicine, vol. 6, no. 1, pp. 19–31, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. T. López, E. Ortiz-Islas, M. López, J. Flores, and T. Corona, “Occlusion of INTERFERON and COPAXONE on SBA-15 silica reservoirs for their use in the treatment of demyelization diseases,” Journal of Nanomaterials & Molecular Nanotechnology, vol. 2, no. 4, pp. 1–6, 2013. View at Google Scholar
  15. T. López, E. Ortiz, P. Quintana, and R. D. González, “A nanostructured titania bioceramic implantable device capable of drug delivery to the temporal lobe of the brain,” Colloids and Surfaces A: Physicochemical and Engineering Aspects, vol. 300, no. 1-2, pp. 3–10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Verraedt, M. Pendela, E. Adams, J. Hoogmartens, and J. A. Martens, “Controlled release of chlorhexidine from amorphous microporous silica,” Journal of Controlled Release, vol. 142, no. 1, pp. 47–52, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Guo, H. Qian, S. Sun et al., “Hollow mesoporous silica nanoparticles for intracellular delivery of fluorescent dye,” Chemistry Central Journal, vol. 5, no. 1, article 1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Zhu, W. Meng, H. Gao, and N. Hanagata, “Hollow mesoporous silica/poly(l-lysine) particles for codelivery of drug and gene with enzyme-triggered release property,” Journal of Physical Chemistry C, vol. 115, no. 28, pp. 13630–13636, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. M. S. Bhattacharyya, P. Hiwale, M. Piras et al., “Lysozyme adsorption and release from ordered mesoporous materials,” Journal of Physical Chemistry C, vol. 114, no. 47, pp. 19928–19934, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Ho, Y. Huang, M. K. Danquah, H. Wang, and G. M. Forde, “Synthesis of biodegradable polymer-mesoporous silica composite microspheres for DNA prime-protein boost vaccination,” European Journal of Pharmaceutical Sciences, vol. 39, no. 5, pp. 412–420, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. T. W. Stone, “Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection,” Trends in Pharmacological Sciences, vol. 21, no. 4, pp. 149–154, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. T. W. Stone and L. G. Darlington, “Endogenous kynurenines as targets for drug discovery and development,” Nature Reviews Drug Discovery, vol. 1, no. 8, pp. 609–620, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Reyes-Ocampo, R. Lugo-Huitrón, D. González-Esquivel et al., “Kynurenines with neuroactive and redox properties: relevance to aging and brain diseases,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 646909, 22 pages, 2014. View at Publisher · View at Google Scholar
  24. S. Erhardt, L. Schwieler, C. Emanuelsson, and M. Geyer, “Endogenous kynurenic acid disrupts prepulse inhibition,” Biological Psychiatry, vol. 56, no. 4, pp. 255–260, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. R. M. Kamiński, E. Zieliński, A. Dekundy, G. van Luijtelaar, and W. A. Turski, “Deficit of endogenous kynurenic acid in the frontal cortex of rats with a genetic form of absence epilepsy,” Polish Journal of Pharmacology, vol. 55, no. 5, pp. 741–746, 2003. View at Google Scholar · View at Scopus
  26. S. Fukui, R. Schwarcz, S. I. Rapoport, Y. Takada, and Q. R. Smith, “Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism,” Journal of Neurochemistry, vol. 56, no. 6, pp. 2007–2017, 1991. View at Publisher · View at Google Scholar · View at Scopus
  27. D. L. Wood and E. M. Rabinovich, “Study of alkoxide silica gels by infrared spectroscopy,” Applied Spectroscopy, vol. 43, no. 2, pp. 263–267, 1989. View at Google Scholar · View at Scopus
  28. T. Lopez, E. Ortiz, R. Alexander-Katz, E. Basaldella, and X. Bokhimi, “Cortisol controlled release by mesoporous silica,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 5, no. 2, pp. 170–177, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. T. López, E. Krötzsch, E. Ortiz-Islas et al., “Release properties and acute biosecurity determination of collagen-polyvinylpyrrolidone loaded in ordered mesoporous silica,” Key Engineering Materials, vol. 391, pp. 169–184, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Ezaby, M. S. T. M. Salem, M. Osman, and M. A. Makhyou, “Spectral studies on some quinoline derivatives of triptophane metabolities,” Indian Journal of Chemistry, vol. 11, pp. 1142–1145, 1973. View at Google Scholar
  31. M. P. Pileni, M. Giraud, and R. Santus, “Kynurenic acid: I. Spectroscopic properties,” Photochemistry and Photobiology, vol. 30, no. 2, pp. 251–256, 1979. View at Google Scholar · View at Scopus
  32. K. S. W. Sing, D. H. Everett, R. A. Haul et al., “Reporting physisorption data for gas/solid systems with special reference to the determination of surface area and porosity,” Pure and Applied Chemistry, vol. 57, no. 4, pp. 603–619, 1985. View at Google Scholar